Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study

BACKGROUND: Mesothelioma is an aggressive thoracic tumour with a poor prognosis. The only treatment that extends survival is chemotherapy. However, in the UK, up to 50% of patients who are suitable for chemotherapy choose not to receive it, opting for active symptom control instead. The aim of this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Palliat Care
Autors principals: Bibby, Anna C., De Fonseka, Duneesha, Morley, Anna J., Keenan, Emma, Addeo, Alfredo, Smith, Sarah, Edey, Anthony J., Maskell, Nick A.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5723074/
https://ncbi.nlm.nih.gov/pubmed/29221485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12904-017-0255-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars